Research Alliance Corp III
RACC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002118032
No open-market purchases or sales by Research Alliance Corp III insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $79.6M in total; no superinvestor holds it.
Superinvestors holding RACC, Q2 2026
No superinvestor reported holding RACC in Q2 2026.